Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is BlossomHill Therapeutics Inc Stock Halal?
Shariah Compliance Analysis of BLSM Stock
No. As of September 2026, BlossomHill Therapeutics Inc (BLSM) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. BlossomHill Therapeutics Inc does not pass Musaffa's business and financial screening criteria.
BlossomHill Therapeutics Inc is a US-based company operating in industry. The company is headquartered in San Diego, California. The company went IPO on 2026-08-07. BlossomHill Therapeutics, Inc. is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop innovative small molecule medicines that address significant unmet medical needs in cancer treatment. The firm is focused on its two clinical-stage programs: BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor being evaluated first in relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS). The company also has a preclinical-stage product candidate, BH-501284, that leverages a novel chemical scaffold to selectively target and modulate activated KRAS. The firm is also advancing multiple discovery-stage efforts focused on validated and emerging new oncology targets.
BLSM Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, BlossomHill Therapeutics Inc is classified as not halal.
NOT HALALBlossomHill Therapeutics Inc (BLSM) Chart
Fetching Price Chart...
Financial Metrics & Statements of BlossomHill Therapeutics Inc (BLSM)
FAQ's for BlossomHill Therapeutics Inc (BLSM)
- As of September 2026, BlossomHill Therapeutics Inc BLSM is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BlossomHill Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in BlossomHill Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of BlossomHill Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of BlossomHill Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of BlossomHill Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for BlossomHill Therapeutics Inc (BLSM)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
